Celldex Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$30.90

+0.87 (+2.90%)

As of Mar 22, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 82%

Hold 3 14%

Sell 1 5%

Price Target

Analyst Price Target +68.5% upside

Low Target $39.61

Average Target $52.08

High Target $81.09

Current Price $30.90

Current
$30.90

Target
$52.08

$39.61 $52.08 avg $81.09

Scenario Analysis

Bear Case

$39.61

28.2%

Low target

Base Case

$52.08

+68.5%

Avg target

Bull Case

$81.09

+162.4%

High target

Risk/Reward

5.8x

Highly favorable

Price in Context

52-Week High

$30.50

1.3% from high

52-Week Low

$14.40

+114.6% from low

Target vs 52W High

$52.08

+70.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%